Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
16.05
+0.22 (1.39%)
At close: Apr 17, 2026, 4:00 PM EDT
16.12
+0.07 (0.44%)
After-hours: Apr 17, 2026, 6:24 PM EDT
Aurinia Pharmaceuticals Employees
Aurinia Pharmaceuticals had 128 employees as of December 31, 2025. The number of employees decreased by 2 or -1.54% compared to the previous year.
Employees
128
Change (1Y)
-2
Growth (1Y)
-1.54%
Revenue / Employee
$2,211,367
Profits / Employee
$2,243,766
Market Cap
2.13B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 128 | -2 | -1.54% |
| Dec 31, 2024 | 130 | -170 | -56.67% |
| Dec 31, 2023 | 300 | 0 | - |
| Dec 31, 2022 | 300 | 0 | - |
| Dec 31, 2021 | 300 | 6 | 2.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Adaptive Biotechnologies | 624 |
| Agios Pharmaceuticals | 540 |
| Syndax Pharmaceuticals | 298 |
| Zymeworks | 264 |
| Capricor Therapeutics | 231 |
| Day One Biopharmaceuticals | 178 |
| Stoke Therapeutics | 170 |
AUPH News
- 18 days ago - Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right - Business Wire
- 25 days ago - MKT Capital Applauds Aurinia Pharmaceuticals' Management Transition - Business Wire
- 25 days ago - Why Aurinia Pharmaceuticals Stock Is Surging Monday Morning - Benzinga
- 25 days ago - Aurinia Announces Management Transition - Business Wire
- 7 weeks ago - Aurinia Pharmaceuticals (AUPH) Stock Drops After Strong Quarter, Softer Forward Revenue Targets - Benzinga
- 7 weeks ago - Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress - Business Wire
- 2 months ago - Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026 - Business Wire
- 5 months ago - Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress - Business Wire